key: cord-0282770-5st3v4ae authors: Bailey, Thomas A.; Apo, Merle M. title: Appendix 6 Pharmaceutical Products Commonly Used in Avian Medicine date: 2016-12-31 journal: nan DOI: 10.1016/b978-0-7234-3832-8.00023-7 sha: 30e77b6f693da0326b9e03f5ffea552e80489f0a doc_id: 282770 cord_uid: 5st3v4ae Unknown 250-mg and 500-mg capsules 125 mg/5 mL and 250 mg/5 mL oral suspension PO 11-15 mg q8h-ratites Broad-spectrum, poor Gl absorption and Gram activity of common bacterial isolates of birds; may be effective when organism is sensitive 25-100 mg/kg q12-24h-pigeons 100-200 mg/kg q6-8hpsittacines 170 mg/L drinking water-game birds 1000-2000 mg/L drinking water-canaries/aviary use 2000-3000 mg/kg soft food-canaries/aviary use 1000 mg/L drinking water-Galliformes flock 125-, 250-, 500-mg, and 1-, 2-, and 10-g phials IM 15 mg/kg q12h-raptors 100 mg/kg q4h-psittacines and most species 155 mg/kg q12-24h-pigeons 100 mg/kg q12h-cranes Amoxicillin favored over ampicillin for IM use in pigeons 4-7 mg/kg q8h-ratites (except emus) Also SC 15-20 mg/kg q12h-emus Also SC Apramycin i.e., Apralan Soluble powder 1-g and 50-g packs 50-, 100-, 200-, and 500-mg and 1-g tablets 50 mg/mL or 100 mg/ mL oral suspension PO 20 mg/kg q12h-ratites 100 mg/kg q12h for 7 d-most species, including pigeons Cephalothin Kefzol (Lily) A first-generation cephalosporin 1-g phials IM 100 mg/kg q6-8h-most species, emus 30-40 mg/kg q6h-ratites 100 mg/kg q 2-3h-quail, ducks 100 mg/kg q 2-6 hr-passerines As the hydrochloride for injection 5%, i.e., 50 mg/mL, 50-mL, and 100-mL phials IM 58 mg/kg q24h for birds weighing more than 400 g; 100 mg for birds weighing less than 400 g Do not be tempted to use the higher concentrations available for large farm animals (e.g., 100 mg/ mL instead of 50 mg/ mL) in an attempt to reduce the bulk of the injection as this only results in tissue necrosis. There is good correlation between MIC values and clinical response. Treatment failure caused by fungal resistance is rare in humans, but Aspergillus spp. are the most frequently reported resistant fungi. Give by slow IV administration with 10-15 mL/kg fluids for 7 d. Absorption from the lungs following aerosol administration is poor and this route is used to treat pulmonary aspergillosis. Improved clinical efficacy when used in combination with flucytosine or azole antifungal agent. Poorly absorbed from the GI tract so must be given IV, IO, or IT. Most important clinical toxicosis is nephrotoxicity, which is dose related and seen clinically as increases in BUN and creatinine in mammals. Dosing every other day, electrolyte loading, and slow infusion of amphotericin B decrease severity and rate of development of renal toxicity. Other adverse effects include phlebitis, fever, nausea, vomiting, and hypokalemia with resulting cardiac arrhythmia. Measures to prevent vomiting include giving antiemetic drugs before infusion. In dogs, doses higher than 5 mg/kg resulted in death caused by cardiac abnormalities; doses of 2-5 mg/kg occasionally caused cardiac problems, but doses lower than 1 mg/kg were without effect on the heart. Treatment protocols should include pretreatment with sodium chloride and it should be infused at a slow rate. It can be mixed with 5% dextrose solution during infusion. Administration of amphotericin B in 0.45% saline with 0.5% dextrose SC in dogs/cats is a way of administering large quantities of amphotericin B without producing the marked azotemia associated with IV Most species Nebulized 1 : 250 dilution 1-3 × d Complete-spectrum virucidal, bactericidal, fungicidal, and sporicidal but aldehyde-free compound of six synergistic active ingredients. Has been tested against every significant animal/human pathogen and has outperformed other disinfectants during efficacy testing, over a range of temperatures, in the presence of organic material, at low concentrations, short contact times, without any corrosive effects on infrastructure, metal nozzles, or any tissue irritation on workers and animals. Can be used to disinfect animal environments in their presence, lowering the environmental pathogen challenge significantly, with no side effects. Using either a nebulizer or a "smogger" unit, has been used to treat both individuals and groups of falcons with aspergillosis. Nebulized at a concentration of 1 : 250 and can also be added at the same concentration to drinking water, where it may limit the spread of bacterial or viral diseases Extensively distributed throughout the body. Hepatometabolized and eliminated mainly in the bile. Therapeutically active concentrations maintained longer in tissues than in plasma. Used to treat superficial and systemic infections and to treat and prevent aspergillosis in birds. As oral absorbtion is pH dependent, dosage adjustments are necessary if gastric pH is increased. Oral capsules should be given with food but the oral suspension is better absorbed on an empty stomach. Higher tissue concentrations are reported when itraconazole is dissolved in acid and gavaged with orange juice in pigeons. Treatment of serious infections should be prolonged (>3 mo) and relapses occur. Better tolerated than ketoconazole. Fewer side effects are seen than with other antifungal agents. Beads dissolve best in 5% acetic acid (cola-based fizzy drinks or orange juice may also be used) left to stand overnight. Diarrhea and inappetence has been associated with the use of this drug in juvenile kori bustards. Dose of 10 mg/ kg for 1 mo considered prophylactic. Sporanox liquid (10 mg/mL) is often more convenient. Twice a day; BUN, blood urea nitrogen DEFRA, Department for Environment, Food and Rural Affairs HI, hemagglutination inhibiting PO, by mouth; qid, four times a day A contribution to preventive medicine and therapeutics of avian captive breeding programmes with special reference to the houbara bustard (Chlamydotis undulata macqueenii) Aerosol therapy using a novel disinfectant to treat upper and lower respiratory tract infections in birds Analysis of amoxicillin in houbara bustard plasma by HPLC after administration of a long-acting formulation Clinical pharmacology and pharmacokinetics of enrofloxacin after intravenous, intramuscular and oral administration in houbara bustard (Chlamydotis undulata macqueenii) A review of Newcastle disease in bustards: presentation, diagnosis and control; results of vaccination trials Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses Clinical avian medicine and surgery Avian medicine and surgery Veterinary formulary Dorrestein GM: The pharmacokinetics of avian therapeutics Antimicrobial drug use in pet birds Dorrestein GM, Verburg E: Pharmacokinetics of enrofloxacin (Baytril) in homing pigeons after different administration routes Flammer K: An overview of antifungal therapy in birds Manual of raptors, pigeons and waterfowl Pharmacokinetics of doxycycline after parenteral administration in the houbara bustard (Chlamydotis undulata) Proceedings of the European Association of Avian Veterinarians Manual of parrots, budgerigars and other psittacine birds Summary of medications for use in psittacine birds Pharmacokinetics of marbofloxacin in broiler chickens after intravenous administration Michell AR: Small animal fluid therapy 2. Solutions and monitoring Trichomonosis: a review of clinical pathology and control in bustard collection Cross-protection of an avian poxvirus isolated from houbara bustards Acute toxicity of high doses of Vitamin B6 (Pyridoxine) in pigeons An introduction to allometric scaling and its uses in raptor medicine Blood formation, coagulation and volume Fluid therapy and acid-base balance in the critically ill avian patient Avian medicine: principles and application Farmacologia e Terapeutica Veterinaria Italia Practical avian therapeutics with dosages of commonly used medications Manual of avian medicine Manual of avian practice Acute toxicity after administration of high doses of Vitamin B6 (Pyridoxine) in falcons Allometric scaling and emergency care: the importance of body size Avian medicine and surgery Essentials of avian medicine and surgery The authors are grateful to Dr. Paolo Zucca from the Laboratory of Animal Cognition and Comparative Neuroscience, Department of Psychology, University of Trieste, Italy for providing most of the information on antiparasitic drugs.